More about

Pediatric Oncology

News
February 02, 2022
2 min read
Save

Caregivers of childhood cancer survivors express hesitancy on COVID vaccination

Caregivers of childhood cancer survivors express hesitancy on COVID vaccination

Many caregivers expressed hesitancy to vaccinate themselves and their children who had cancer against COVID-19, according to study results published in Pediatric Blood & Cancer.

News
February 02, 2022
2 min read
Save

Chemotherapy-free regimen benefits children with acute promyelocytic leukemia

Chemotherapy-free regimen benefits children with acute promyelocytic leukemia

Children with acute promyelocytic leukemia achieved survival benefit with an all-trans retinoic acid and arsenic trioxide chemotherapy-free regimen, according to study results published in JAMA Oncology.

News
January 31, 2022
2 min read
Save

Clinicians often don’t recognize parent challenges in therapeutic relationships

Clinicians often don’t recognize parent challenges in therapeutic relationships

Many parents of children with cancer experienced challenges in the therapeutic relationship with their child’s treating oncologist, according to study results published in JAMA Network Open.

News
January 31, 2022
6 min read
Save

Out-of-spec CAR-T appears safe, effective for younger patients with ALL

Out-of-spec CAR-T appears safe, effective for younger patients with ALL

B-cell acute lymphoblastic leukemia is the most common type of cancer among children.

News
January 06, 2022
3 min read
Save

Younger Hispanic/Latinx patients face access barriers to CAR-T clinical trials

Younger Hispanic/Latinx patients face access barriers to CAR-T clinical trials

Younger Hispanic/Latinx patients face many barriers that may limit timely access to chimeric antigen receptor T-cell therapy trials for relapsed or refractory B-cell acute lymphoblastic leukemia, according to retrospective study results.

News
January 04, 2022
1 min read
Save

FDA grants rare pediatric disease designation to IMX-110 for rhabdomyosarcoma

FDA grants rare pediatric disease designation to IMX-110 for rhabdomyosarcoma

The FDA granted rare pediatric disease designation to IMX-110 for treatment of children with rhabdomyosarcoma.

News
December 14, 2021
2 min read
Save

Researchers uncover new subtype of pediatric AML defined by UBTF tandem duplications

Researchers uncover new subtype of pediatric AML defined by <i>UBTF</i> tandem duplications

Upstream binding transcription factor tandem duplications, or UBTF-TDs, identified through integrated genomic analysis represent a new subtype of acute myeloid leukemia that previously had no known oncogenic driver, study results showed.

News
December 13, 2021
3 min read
Save

Ibrutinib plus chemoimmunotherapy confers durable responses in younger patients with CLL

Ibrutinib plus chemoimmunotherapy confers durable responses in younger patients with CLL

Most patients with chronic lymphocytic leukemia who received ibrutinib plus fludarabine, cyclophosphamide and rituximab continued to maintain deep responses after longer-term follow-up, results of a single arm, phase 2 trial showed.

News
November 19, 2021
4 min read
Save

Task force focuses on quality-of-life issues ‘most relevant to our AYAs’ with cancer

Task force focuses on quality-of-life issues &lsquo;most relevant to our AYAs&rsquo; with cancer

Cancer in adolescents and young adults has become an important area of focus in oncology research.

News
November 09, 2021
3 min read
Save

Preterm birth drug given to millions of women may increase cancer risk in offspring

Preterm birth drug given to millions of women may increase cancer risk in offspring

The offspring of mothers who received 17-hydroxyprogesterone caproate during pregnancy may face nearly double the risk for cancer compared with those who were not exposed, according to a recent study.

View more